Conférences - Pharmacologie et développement des médicaments

Endeavor Research

In the series of two successful webinars, Endeavor Research PVT Limited continuing the inspiration of gathering researchers with the upcoming 3rd Edition of Webinar on Pharmaceutical Science and Drug Development which will be slated hold from January 24-25, 2022. It is your single best opportunity to reach the largest assemblage of participants from all over the globe who are focused on learning about Pharmaceutics and its advancements.

Pharma-2022 webinar will explore the latest in R&D and will provide a multidisciplinary programme covering more traditional themes as well as very latest issues and novel developments in the field of Pharmaceutical Science.

Tél.: [+1 (209) 299 5348];     Email.: pharma.endeavor@gmail.com

Biopharmaceutical Drug Design and Development, Pharmaceutical Chemistry and Research Advancements, Pharmaceutical Formulation Technologies, COVID-19: Drug Development and Delivery System, Current Therapeutic Drugs Treating COVID-19, Molecular Modelling in Drug Designing, Novel Drug Delivery Systems, Clinical Pharmacology and Translational Research, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Formulation Design and Development, Pharmaceutical Nanotechnology, Herbal Novel Drug Delivery and Traditional Medicine, Pharmaceutical Microbiology and Biotechnology, Drug Discoveries and Therapeutics, Advances in Clinical trials, AI and Machine learning for Drug Discovery, Regenerative medicine, Pharmacy Practice and Clinical Pharmacy, Drug Development in Neurology and Disorders, Innovative Drug Development, Pharmaceutical Innovative Technologies and Manufacturing

SMi Group

The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.

The 2022 agenda will explore innovations in novel and targeted delivery, RNAi innovations and antisense oligonucleotide therapeutics. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of RNA with case studies on the treatment of cardiovascular disease, neurological diseases, and oncology.

Tél.: [02078276000];     Email.: ngaloria@smi-online.co.uk

Small interfering RNA, siRNA, Antisense therapy, DNA, RNA, nucleic acid, mRNA, Micro RNA, RNA-induced silencing complex, RISC, Aptamers, oligonucleotide, peptide molecules, Immunogenicity, Drug pipeline, short interfering RNA, silencing RNA, RNA interference, RNAi, mRNA degradation

Pharma Market Research Conference

The 2022 Pharma Market Research Conference (February 9-10, 2022, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 10+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.

Event Manager;     Tél.: [+1-212-228-7974];     Email.: ross@pharmamarketresearchconference.com

The Royal Society of Chemistry

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

DMPK and Drug Discovery - DMPK and Drug Safety

Virtue Insight

After the successful journey of a series of 26 Pharmacovigilance conferences, Virtue Insight is proud to announce its 27th Pharmacovigilance 2022. We have been delivering the conference through close collaboration with the industry leaders for more than a decade. For the 2022 edition, the agenda includes a host of new and exciting features focusing on how the industry should evolve especially after the pandemic. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level.

Tél.: [+44 2035093779];     Email.: kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

Virtue Insight

10th Annual Pharma AntiCounterfeiting & Serialisation 2022 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems, this conference addresses serialisation, track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. It gives us immense pleasure in welcoming you to “10th Annual Pharma Anti-Counterfeiting & Serialisation 2022 – “Competences to Combat Counterfeits”

Tél.: [+44 2035093779];     Email.: kavitha@virtueinsight.co.in

Anticounterfeiting, Serialisation, Pharmaceuticals, Counterfeit, Supply Chain, Track Trace, Drug regulatory, Packaging, labeling, Blockchain, ArtificialIntelligence, IoT

The Royal Society of Chemistry

This conference in the series will concentrate on the testing of cosmetic formulation both in terms of stability and final performance.

Biochimie et chimie médicale, toxicologie ,    Chimie cosmétique et détergents

SMi Group

Device innovations, connected delivery and regulatory guidance for advanced parenteral systems

The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. As part of SMi’s leading injectable series, the 2022 conference will provide an exclusive insight into the latest developing technologies for device design, advances in parenteral device platforms and development, insights into growing integration of digital health and deep dives into recent case studies on novel delivery systems.

This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

Visit the website at: https://www.smi-online.co.uk/pharmaceuticals/northamerica/prefilled-syringes-east-coast

Tél.: [+442078276088];     Email.: Rjones@smi-online.co.uk

Pre-Filled Syringes, Injectable Drug Devices, drug development, regulatory guidelines, pharmaceutical industry, drug delivery, therapeutic sectors, vaccines, Parenteral administration, combination products, primary packaging, sterile injectables, connectivity, human factors, autoinjectors

iPharma

iPharma Expo 2022, USA (International Pharmaceutical Business Expo 2022) scheduled during May 26- 27, 2022, at Boston, U.S.A. This expo will showcase the latest trends and technologies in pharmaceuticals, drugs and formulations and will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries. iPharma Expo 2022 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry, management etc. bringing unique platform for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries.

Tél.: [6193784851];     Email.: info@ipharmaexpo.com

Phrarmacology, Pharma Manufacturing, Pharma Market

The Royal Society of Chemistry

The school is designed for graduate and post-doctoral chemists with 1-5 years’ experience in the field of drug research. Drug discovery is an interdisciplinary subject so delegates from biological or computational backgrounds will benefit from attendance at the school. In addition, final year PhD students from pharmaceutical or organic chemistry contemplating a career in drug discovery are also encouraged to attend.

The Royal Society of Chemistry Medicinal Chemistry Residential School will cover topics of interest to drug discovery researchers, helping to increase understanding of the factors governing modern drug discovery from the initial concept through to translational science and intellectual property. Established since 1981, our Residential School has trained many of the world’s leading medicinal chemists working in the pharmaceutical industry and academic research institute.

Biochimie et chimie médicale, toxicologie ,    Cours et événements pour étudiants en chimie

SCI (Society of Chemical Industry)

Immunotherapy is a hot-topic field of research that has generated significant scientific interest and fuelled industrial innovation. It has been demonstrated that small, drug-like molecules can be highly effective modulators of immune response pathways and that their molecular properties can be fine-tuned to enable excellent cell permeability and bioavailability. This makes them ideal for use in the treatment of chronic conditions such as autoimmune and inflammation-related diseases. Excitingly, this approach also offers the possibility to treat cancer by harnessing the body’s own immune system to fight tumours. This meeting will offer a broad introduction to those new to the topic and showcase recent innovations by academic and industrial scientists in this exciting and rapidly expanding field.

Conferences Team;     Tél.: [+44 (0)20 7598 1561];     Email.: conferences@soci.org

immunotherapy, drug discovery, immuno-oncology cellular immunology, molecular immunology, novel drug delivery systems, cancer immunotherapy, small molecule inhibitors, drug discovery and development obstacles, cell immunotherapy, immunology

compliance4all

Overview:

FDA and EU regulations require that firms have a program for the calibration and maintenance of test and measurement equipment.

The program must include: intervals, scheduling, specific procedures, limits of accuracy/precision, and remedial action in the event that the equipment does not meet established requirements.

Compliance4all;     Tél.: [8004479407];     Email.: support@compliance4All.com